MXPA05013596A - Antagonistas de hormona concentradora de melanina para el tratamiento de obesidad. - Google Patents
Antagonistas de hormona concentradora de melanina para el tratamiento de obesidad.Info
- Publication number
- MXPA05013596A MXPA05013596A MXPA05013596A MXPA05013596A MXPA05013596A MX PA05013596 A MXPA05013596 A MX PA05013596A MX PA05013596 A MXPA05013596 A MX PA05013596A MX PA05013596 A MXPA05013596 A MX PA05013596A MX PA05013596 A MXPA05013596 A MX PA05013596A
- Authority
- MX
- Mexico
- Prior art keywords
- mch
- antagonists
- obesity
- treatment
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion describe metodos para usar antagonistas para hormona concentradora de melanina (MCH), para tratar obesidad, trastornos metabolicos, trastornos de la alimentacion tales como hiperfagia, y diabetes, asi como compuestos novedosos que son antagonistas para hormona concentradora de melanina (MCH); en otros aspectos, la invencion esta dirigida a composiciones farmaceuticas que comprenden dichos antagonistas de MCH asi como metodos para preparar dichos compuestos; los compuestos de la invencion generalmente tienen la estructura de la formula (I) (ver formula (I)) en donde los sustituyentes son como se define aqui.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48361903P | 2003-06-30 | 2003-06-30 | |
PCT/US2004/020763 WO2005005419A1 (en) | 2003-06-30 | 2004-06-28 | Mch antagonists for the treatment of obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05013596A true MXPA05013596A (es) | 2006-03-09 |
Family
ID=34061963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05013596A MXPA05013596A (es) | 2003-06-30 | 2004-06-28 | Antagonistas de hormona concentradora de melanina para el tratamiento de obesidad. |
Country Status (7)
Country | Link |
---|---|
US (1) | US7345042B2 (es) |
EP (1) | EP1644366A1 (es) |
JP (1) | JP4605801B2 (es) |
CN (1) | CN1812985A (es) |
CA (1) | CA2526725A1 (es) |
MX (1) | MXPA05013596A (es) |
WO (1) | WO2005005419A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7678798B2 (en) | 2004-04-13 | 2010-03-16 | Incyte Corporation | Piperazinylpiperidine derivatives as chemokine receptor antagonists |
WO2007124045A2 (en) * | 2006-04-20 | 2007-11-01 | Ampla Pharmaceuticals, Inc. | Piperidine and piperazine compounds for use in the treatment of obesity, eating disorders and sexual dysfunction by potentiation of mc4 receptor activity |
US20080108586A1 (en) * | 2006-09-06 | 2008-05-08 | Incyte Corporation | Combination therapy for human immunodeficiency virus infection |
AU2018289303B2 (en) | 2017-06-20 | 2023-12-21 | Imbria Pharmaceuticals, Inc. | Compositions and methods for increasing efficiency of cardiac metabolism |
US11780811B2 (en) | 2020-06-30 | 2023-10-10 | Imbria Pharmaceuticals, Inc. | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11530184B2 (en) | 2020-06-30 | 2022-12-20 | Imbria Pharmaceuticals, Inc. | Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11883396B2 (en) | 2021-05-03 | 2024-01-30 | Imbria Pharmaceuticals, Inc. | Methods of treating kidney conditions using modified forms of trimetazidine |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5889006A (en) | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
IL117149A0 (en) | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
US5908830A (en) | 1996-10-31 | 1999-06-01 | Merck & Co., Inc. | Combination therapy for the treatment of diabetes and obesity |
CZ20013940A3 (cs) | 1999-05-04 | 2002-04-17 | Schering Corporation | Piperazinové deriváty uľitečné jako CCR5 antagonisté |
US6391865B1 (en) * | 1999-05-04 | 2002-05-21 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
US6569861B2 (en) * | 2000-07-06 | 2003-05-27 | Neurogen Corporation | Melanin concentrating hormone receptor ligands |
US6900329B2 (en) * | 2001-03-21 | 2005-05-31 | Schering Corporation | MCH antagonists and their use in the treatment of obesity |
CA2448080A1 (en) * | 2001-05-22 | 2002-11-28 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
MXPA04004956A (es) * | 2001-11-26 | 2004-08-11 | Schering Corp | Antagonistas de la hormona concentradora de melanina basados en la piperidina para tratamiento de la obesidad y de trastornos del sistema nervioso central. |
US6906075B2 (en) * | 2002-01-10 | 2005-06-14 | Neurogen Corp. | Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
US7160886B2 (en) * | 2003-03-03 | 2007-01-09 | Merck & Co., Inc. | Acylated piperazine derivatives as melanocortin-4 receptor agonists |
MXPA05013474A (es) * | 2003-06-13 | 2006-03-09 | Schering Ag | Derivados de quinolilamida como antagonistas de ccr-5. |
-
2004
- 2004-06-28 CN CNA2004800183172A patent/CN1812985A/zh active Pending
- 2004-06-28 WO PCT/US2004/020763 patent/WO2005005419A1/en active Application Filing
- 2004-06-28 CA CA002526725A patent/CA2526725A1/en not_active Abandoned
- 2004-06-28 JP JP2006517746A patent/JP4605801B2/ja not_active Expired - Fee Related
- 2004-06-28 MX MXPA05013596A patent/MXPA05013596A/es not_active Application Discontinuation
- 2004-06-28 EP EP04777221A patent/EP1644366A1/en not_active Withdrawn
- 2004-06-28 US US10/878,788 patent/US7345042B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7345042B2 (en) | 2008-03-18 |
JP4605801B2 (ja) | 2011-01-05 |
US20050004121A1 (en) | 2005-01-06 |
JP2007521286A (ja) | 2007-08-02 |
EP1644366A1 (en) | 2006-04-12 |
CA2526725A1 (en) | 2005-01-20 |
WO2005005419A1 (en) | 2005-01-20 |
CN1812985A (zh) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04003858A (es) | Antagonistas de mch para el tratamiento de obesidad. | |
MXPA04004956A (es) | Antagonistas de la hormona concentradora de melanina basados en la piperidina para tratamiento de la obesidad y de trastornos del sistema nervioso central. | |
TW200531689A (en) | Therapeutic agents | |
EA200900658A1 (ru) | Производные индазолилэфиров или -амидов для лечения расстройств, опосредованных глюкокортиодными рецепторами | |
PH12012501640A1 (en) | Novel compounds as opioid receptor modulators | |
MXPA04000707A (es) | Nuevos antagonistas del receptor y5 del neuropeptido y referencia cruzada a solicitudes relacionadas. | |
TW200635903A (en) | Therapeutic agents | |
BR0208150A (pt) | Antagonistas de mch e sua aplicação no tratamento da obesidade | |
TW200504034A (en) | Therapeutic agents | |
WO2003028641A3 (en) | Mch receptor antagonists | |
MXPA05010712A (es) | Derivados de quinolin-2-ona para el tratamiento de enfermedades de las vias respiratorias. | |
TW200720260A (en) | Prokineticin 1 receptor antagonists | |
EA200601266A1 (ru) | Соединения триазола и их применение в качестве антагонистов метаботропного рецептора глутамата | |
TW200716566A (en) | Prokineticin 2 receptor antagonists | |
HRP20080689T3 (en) | Imidazoline derivatives having cb1-antagonistic activity | |
TW200611695A (en) | Pyrrolopyridine derivatives | |
IS8377A (is) | Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns | |
HK1079526A1 (en) | A novel pyrazine compound and its use in the manufacture of a medicament for treating diseases related to serotonin | |
SI1745010T1 (sl) | Substituirani cikloheksil-1,4-diaminski derivati | |
TW200734324A (en) | Therapeutic agents | |
MY139454A (en) | 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists | |
MXPA05009193A (es) | Biariltetrahidroisoquinolina piperidinas como antagonistas receptores selectivos de la hormona que concentra la melanina para el tratamiento de la obesidad y trastornos relacionados. | |
MXPA05013596A (es) | Antagonistas de hormona concentradora de melanina para el tratamiento de obesidad. | |
TW200505869A (en) | Thiophenylaminoimidazolines | |
MX2009005504A (es) | Derivados de espiro piperidina como antagonistas del receptor via. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |